Myelodysplastic Syndrome

DBCOND0028333Hemic and Lymphatic DiseasesNeoplasms

Myelodysplastic Syndrome is the indication for 6 drugs in DrugBank. It is covered by 26 curated, structured indications.

Also known as
Preleukemia · myelodysplastic disease · Myelodysplastic Syndromes · Myelodysplastic Disorders · Myelodysplasia
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0014324ICD-10D46SNOMED CT109995007MedDRA10028536UMLSC0033027

What you can answer from here — as of October 22, 2026

6Indicated drugsWith each drug's targets and mechanism
Listed above
26Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
2,089Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Boxed warningsLabel boxed warnings that name this condition
Sign in
27Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Myelodysplastic Syndrome share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In